Watch this exclusive interview with Richard Banks, chief strategy officer and European managing director of global fertility company Virtus Health, as he shares valuable insights into the evolving market landscape.

Richard dives into the impact of the post-COVID market on the fertility sector, highlighting the initial surge in demand and subsequent stabilisation. He discusses critical jurisdictions, including Denmark, Ireland, and the UK, shedding light on market trends, patient demographics, and the exciting possibilities in each region.

Technology’s role in fertility treatment takes centre stage as Richard explores the potential of AI in embryo selection and the fascinating developments in cryogenic freezing and remote monitoring. He shares his perspective on the challenges facing the industry, such as declining birth rates and changing social dynamics, while also emphasising the sector’s positive impact on individuals and society.